Latest filing published 07 Feb 2020 for CLS AB, €7,606.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Karl Göran Tranberg: trading record in brief
Karl Göran Tranberg discloses dealings in 2 companies, chiefly Clinical Laserthermia Systems and CLS AB. In total, 3 filings cover trades dated from 30 May 2018 to 4 February 2020.
In open-market terms, that means 1 purchase worth €7,606 on one side and 1 sale on the other. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2020: 1 purchase and no sales on the market.
The newest entry dates from 7 February 2020: an open-market purchase of €7,606, in CLS AB. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Karl Göran Tranberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,000 shares@ SEK 5.80100.0% of flowBTA (betald tecknad aktie)ISIN SE0011282060FI:csv-dd7982be6d7080a85ea7Canonical exit: 4 May 2020 (T+90)
- 1,287,499 shares0ISIN SE0011282060FI:csv-cc6b3c45ec9fe3e5d0c7
- 30,000 shares@ SEK 8.50100.0% of flowISIN SE0011282078FI:csv-64445d8feb31007d3fc0
3 of 3 declarations